 William Mustain
Concepts (100)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Evoked Myogenic Potentials | 4 | 2022 | 5 | 0.510 |
Why?
| | Vestibule, Labyrinth | 5 | 2013 | 14 | 0.470 |
Why?
| | Acoustic Stimulation | 5 | 2022 | 93 | 0.360 |
Why?
| | Otolithic Membrane | 3 | 2022 | 3 | 0.250 |
Why?
| | Neck Muscles | 2 | 2016 | 5 | 0.220 |
Why?
| | Oculomotor Muscles | 2 | 2010 | 22 | 0.170 |
Why?
| | Colorectal Neoplasms | 2 | 2015 | 294 | 0.160 |
Why?
| | Drug Carriers | 1 | 2015 | 73 | 0.110 |
Why?
| | RNA, Viral | 1 | 2015 | 127 | 0.110 |
Why?
| | Surgical Flaps | 2 | 2006 | 110 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 6 | 2022 | 1563 | 0.110 |
Why?
| | Sound | 1 | 2013 | 10 | 0.110 |
Why?
| | Neurons, Afferent | 1 | 2013 | 23 | 0.110 |
Why?
| | Nanoparticles | 1 | 2015 | 160 | 0.100 |
Why?
| | Mastoid | 1 | 2012 | 51 | 0.100 |
Why?
| | Rats | 6 | 2022 | 3220 | 0.090 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 24 | 0.090 |
Why?
| | Vestibular Nuclei | 1 | 2010 | 9 | 0.090 |
Why?
| | Reflex, Vestibulo-Ocular | 1 | 2010 | 5 | 0.090 |
Why?
| | Wakefulness | 1 | 2010 | 49 | 0.090 |
Why?
| | Neural Pathways | 1 | 2010 | 96 | 0.080 |
Why?
| | Electromyography | 1 | 2010 | 127 | 0.080 |
Why?
| | Animals | 10 | 2022 | 13505 | 0.080 |
Why?
| | Nystagmus, Optokinetic | 1 | 2008 | 1 | 0.070 |
Why?
| | Nystagmus, Physiologic | 1 | 2008 | 3 | 0.070 |
Why?
| | Fixation, Ocular | 1 | 2008 | 12 | 0.070 |
Why?
| | Models, Neurological | 1 | 2008 | 52 | 0.070 |
Why?
| | Bone Substitutes | 1 | 2007 | 8 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 804 | 0.070 |
Why?
| | Peripheral Nerve Injuries | 1 | 2006 | 14 | 0.060 |
Why?
| | Male | 12 | 2016 | 26761 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2006 | 182 | 0.060 |
Why?
| | Signal Transduction | 1 | 2012 | 1671 | 0.060 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2004 | 14 | 0.060 |
Why?
| | Rectus Abdominis | 1 | 2004 | 10 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2006 | 1478 | 0.050 |
Why?
| | Bone and Bones | 1 | 2007 | 494 | 0.050 |
Why?
| | Acoustics | 1 | 2022 | 34 | 0.050 |
Why?
| | Models, Animal | 2 | 2013 | 234 | 0.040 |
Why?
| | Liver Neoplasms | 2 | 2015 | 333 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 1470 | 0.040 |
Why?
| | Reference Values | 2 | 2010 | 313 | 0.030 |
Why?
| | Adult | 4 | 2016 | 14161 | 0.030 |
Why?
| | Posture | 1 | 2016 | 66 | 0.030 |
Why?
| | Bacillus Phages | 1 | 2015 | 2 | 0.030 |
Why?
| | RNA Stability | 1 | 2015 | 25 | 0.030 |
Why?
| | Folate Receptor 1 | 1 | 2015 | 27 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2015 | 220 | 0.030 |
Why?
| | Semicircular Canals | 1 | 2013 | 12 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 133 | 0.030 |
Why?
| | Base Sequence | 1 | 2015 | 640 | 0.030 |
Why?
| | Action Potentials | 1 | 2013 | 120 | 0.030 |
Why?
| | Time Factors | 2 | 2013 | 2968 | 0.030 |
Why?
| | Saccule and Utricle | 1 | 2012 | 2 | 0.030 |
Why?
| | Reaction Time | 1 | 2013 | 209 | 0.030 |
Why?
| | Mice | 2 | 2015 | 5949 | 0.030 |
Why?
| | Humans | 6 | 2016 | 52483 | 0.020 |
Why?
| | Paxillin | 1 | 2012 | 4 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2012 | 11 | 0.020 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2012 | 14 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 19 | 0.020 |
Why?
| | Lipogenesis | 1 | 2012 | 31 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 108 | 0.020 |
Why?
| | Afferent Pathways | 1 | 2011 | 12 | 0.020 |
Why?
| | Vestibular Nerve | 1 | 2011 | 5 | 0.020 |
Why?
| | Mice, Nude | 1 | 2012 | 265 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 220 | 0.020 |
Why?
| | Caloric Tests | 1 | 2010 | 2 | 0.020 |
Why?
| | Electrooculography | 1 | 2010 | 12 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 857 | 0.020 |
Why?
| | Evoked Potentials, Visual | 1 | 2010 | 28 | 0.020 |
Why?
| | Eye Movements | 1 | 2010 | 21 | 0.020 |
Why?
| | Electrodes | 1 | 2010 | 35 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 346 | 0.020 |
Why?
| | Macaca mulatta | 1 | 2010 | 92 | 0.020 |
Why?
| | Models, Biological | 1 | 2012 | 735 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2015 | 636 | 0.020 |
Why?
| | Dominance, Ocular | 1 | 2008 | 1 | 0.020 |
Why?
| | Vestibular Function Tests | 1 | 2008 | 7 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2008 | 29 | 0.020 |
Why?
| | Female | 3 | 2016 | 28171 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 183 | 0.020 |
Why?
| | Bone Matrix | 1 | 2007 | 16 | 0.020 |
Why?
| | Neural Conduction | 1 | 2006 | 34 | 0.020 |
Why?
| | Peripheral Nerves | 1 | 2006 | 44 | 0.020 |
Why?
| | Young Adult | 1 | 2016 | 4329 | 0.020 |
Why?
| | Necrosis | 1 | 2006 | 176 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 375 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2010 | 1678 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2010 | 2279 | 0.010 |
Why?
| | Tissue Transplantation | 1 | 2004 | 8 | 0.010 |
Why?
| | Probability | 1 | 2004 | 172 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2004 | 183 | 0.010 |
Why?
| | Graft Survival | 1 | 2004 | 160 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2004 | 554 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 582 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 891 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 979 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 1132 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 13028 | 0.010 |
Why?
|
|
Mustain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|